Business Medical Dialogues
    • facebook
    • twitter
    Sign in Signup
    • facebook
    • twitter
    Sign in Signup
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    Sign InRegister
    Business Medical Dialogues
    Sign inRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • dpco

    Tag: dpco

    You Searched For "dpco"
    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

    Medical Dialogues Bureau5 July 2019 12:28 PM GMT
    As per provisions of DPCO, all manufacturers of Scheduled medicines (branded or generic) have to sell their products within the ceiling price fixed by ...
    NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details

    NPPA fixes retail price of 9 combo drugs including Metformin, Paracetamol; Details

    Farhat Nasim4 July 2019 9:10 AM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 6:14 AM GMT
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority ...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 12:14 PM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 5:53 AM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Prices of 21 New Drugs fixed by NPPA; Details

    Prices of 21 New Drugs fixed by NPPA; Details

    Meghna A Singhania4 April 2019 4:30 AM GMT
    The NPPA order is likely to affect drug majors including Torrent Pharma, Alkem Laboratories, Zydus Pharmaceuticals, Cadila Healthcare, Mylan, Cipla, He...
    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

    NPPA revises ceiling price of 847 formulations including Metformin, Atrovastatin; Details

    Meghna A Singhania3 April 2019 12:38 PM GMT
    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices of 847 formulations under the...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 8:03 AM GMT
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

    NPPA revises ceiling prices of 14 drug formulations including Injections, Inhalators; Details

    Meghna A Singhania3 March 2019 5:15 AM GMT
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) revises the ceiling...
    NPPA caps trade margins to 30 percent for 42 cancer drugs

    NPPA caps trade margins to 30 percent for 42 cancer drugs

    Meghna A Singhania28 Feb 2019 3:50 AM GMT
    As per data available with NPPA, the MRP for 105 brands will be reduced up to 85 per cent entailing minimum saving of Rs 105 crore to consumers, it add...
    Launching product without Approval: DOP rejects Biocon Plea against NPPA action

    Launching product without Approval: DOP rejects Biocon Plea against NPPA action

    Meghna A Singhania24 Feb 2019 5:55 AM GMT
    New Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
    NPPA fixes retail price of Emcure pharma

    NPPA fixes retail price of Emcure pharma's HIV drug

    Meghna A Singhania17 Feb 2019 4:00 AM GMT
    New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 29 March 2022 11:15 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X